The estimated Net Worth of Leon Chen is at least 108 千$ dollars as of 1 January 2021. Leon Chen owns over 3,298 units of ContextLogic Inc stock worth over 17,644$ and over the last 6 years he sold LOGC stock worth over 0$. In addition, he makes 89,869$ as Independent Director at ContextLogic Inc.
Sign up
Leon Chen LOGC stock SEC Form 4 insiders trading
Leon has made over 1 trades of the ContextLogic Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 3,298 units of LOGC stock worth 17,644$ on 1 January 2021.
The largest trade he's ever made was exercising 3,298 units of ContextLogic Inc stock on 1 January 2021 worth over 17,644$. On average, Leon trades about 412 units every 0 days since 2018. As of 1 January 2021 he still owns at least 3,298 units of ContextLogic Inc stock.
You can see the complete history of Leon Chen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Leon Chen biography
Dr. Leon Chen Ph.D. serves as Independent Director of the Company. Dr. Chen is a partner at The Column Group, a healthcare investment firm, where he has been employed since October 2019. Prior to joining The Column Group, Dr. Chen was a venture partner at OriMed Advisors, a healthcare investment firm, where he had been employed since June 2013. Dr. Chen currently serves on the boards of several privately held life sciences companies. He has a B.A. in biochemistry from U.C. Berkeley, a Ph.D. in molecular pharmacology from Stanford and an M.B.A. from the Stanford Graduate School of Business. Chen’s venture capital experience, especially his experience investing in life sciences companies, provides him with the qualifications and skills to serve as a director.
What is the salary of Leon Chen?
As the Independent Director of ContextLogic Inc, the total compensation of Leon Chen at ContextLogic Inc is 89,869$. There are 9 executives at ContextLogic Inc getting paid more, with Frederic Chereau M.B.A. having the highest compensation of 677,202$.
How old is Leon Chen?
Leon Chen is 45, he's been the Independent Director of ContextLogic Inc since 2016. There are 13 older and 4 younger executives at ContextLogic Inc. The oldest executive at ContextLogic Inc is Richard Moscicki, 68, who is the Independent Director.
What's Leon Chen's mailing address?
Leon's mailing address filed with the SEC is C/O LOGICBIO THERAPEUTICS, INC., 65 HAYDEN AVE, FLOOR 2, LEXINGTON, MA, 02421.
Insiders trading at ContextLogic Inc
Over the last 6 years, insiders at ContextLogic Inc have traded over 4,601,420$ worth of ContextLogic Inc stock and bought 6,882,964 units worth 56,977,784$ . The most active insiders traders include Tomer Kariv、Advisors Llc Orbi Med Capit...、Mark J Enyedy. On average, ContextLogic Inc executives and independent directors trade stock every 97 days with the average trade being worth of 1,869,237$. The most recent stock trade was executed by Brett Just on 15 August 2024, trading 6,465 units of LOGC stock currently worth 34,588$.
What does ContextLogic Inc do?
wish is a mobile e-commerce platform that connects hundreds of millions of consumers with the widest selection of products delivered directly to their doors. our mission is to provide everyone access to the most affordable and convenient shopping experience on the planet. wish supports 500,000 merchant partners as well as over 300 million users who rate wish the best mobile shopping app on the ios and android platforms. founded in 2011, wish has raised over a billion dollars from top funds, such as temasek, dst, ggv capital, founders fund, and jerry yang’s ame cloud. wish is headquartered in san francisco, with additional offices in shanghai, toronto, dublin, amsterdam, and more.
What does ContextLogic Inc's logo look like?
Complete history of Leon Chen stock trades at ContextLogic Inc、Nurix Therapeutics
ContextLogic Inc executives and stock owners
ContextLogic Inc executives and other stock owners filed with the SEC include:
-
Frederic Chereau M.B.A.,
Pres, CEO & Director -
Seokho Yoon,
-
Frederic Chereau,
President, Chief Executive Officer, Director -
Dr. Daniel J. Gruskin M.D.,
Chief Medical Officer -
Mariana Nacht Ph.D.,
Chief Scientific Officer -
Mark Kay,
Independent Director -
Dr. Mark A. Kay M.D., Ph.D.,
Co-Founder, Chairman of Scientific Advisory Board & Independent Director -
Michael Wyzga,
Independent Director -
Erez Chimovits,
Independent Director -
Leon Chen,
Independent Director -
Richard Moscicki,
Independent Director -
Daniel O'Connell,
Independent Director -
Kyle Chiang,
Chief Operating Officer -
Daniel Gruskin,
Interim Head of Clinical Development -
Brian Luque,
Associate Director, Investor Relations -
Mark Enyedy,
Independent Director -
Matthias Jaffe,
Chief Financial Officer -
Grace Lochhead,
VP & Head of HR -
Dr. Leszek Lisowski M.B.A., Ph.D.,
Co-Founder & Member of Scientific Advisory Board -
Matthias B. Jaffe,
Consultant -
Andrea Paul,
Gen. Counsel & Corp. Sec. -
Dr. Matthias Hebben,
Global VP & Head of Technology Devel. -
Cecilia Jones,
Chief Financial Officer -
Dr. Adi Barzel Ph.D.,
Co-Founder -
Dr. Leszek Lisowski Ph.D.,
Co-Founder -
Mariana Nacht,
Chief Scientific Officer -
Brett Just,
Chief Financial Officer -
Bioscience Plc Arix Bioscie...,
-
Tomer Kariv,
Director -
Sofia Ioannidou,
Director -
Thomas Wilton,
Chief Business Officer -
Dean Falb,
Chief Scientific Officer -
Advisors Llc Orbi Med Capit...,
-
Kenneth Huttner,
SVP, Head of Clinical Dev. -
Advisors Llc Orbi Med Capit...,
-
Cecilia Jones,
Chief Financial Officer -
Daphne Karydas,
Director -
Jeff Goater,
Director -
Susan Kahn,
Director -
Andrea Paul,
General Counsel and Secretary -
Joanna Forster,
General Counsel & CCO